Anna Linder
-
Inhibition of STAT3 prevents bone metastatic progression of prostate cancer in
vivo
Malin Hagberg Thulin, J. Maatta, Anna Linder, S. Sterbova, Claes Ohlsson, Jan-Erik Damber, A. Widmark, E. Persson
Prostate - 2021-01-01 -
Evaluation of Sialyl-Lactotetra as a Marker for Epithelial Ovarian
Tumors
Angela Barone, Anna Linder, Constantina Mateoiu, R. K. Larsen, O. Blixt, Susann Teneberg, Karin Sundfeldt
Frontiers in Oncology - 2020-01-01 -
RGS2 is prognostic for development of castration resistance and cancer-specific survival in castration-resistant prostate
cancer
Anna Linder, Karin Larsson, Karin Welén, Jan-Erik Damber
Prostate - 2020-01-01 -
Evaluation of regulator of G-protein signaling 2 (RGS2) at different stages of prostate cancer - Significance and clinical
potential
Anna Linder
- 2019-01-01 -
Analysis of regulator of G-protein signalling 2 (RGS2) expression and function during prostate cancer
progression
Anna Linder, M. Hagberg Thulin, Jan-Erik Damber, Karin Welén
Scientific Reports - 2018-01-01 -
Circulating Tumor Cells as a Marker for Progression-free Survival in Metastatic Castration-naïve Prostate
Cancer.
Andreas Josefsson, Anna Linder, Despina Flondell Site, Giacomo Canesin, Anna Stiehm, Aseem Anand, Anders Bjartell, Jan-Erik Damber, Karin Welén
The Prostate - 2017-01-01 -
Analysis of an independent tumor suppressor locus telomeric to Tp53 suggested Inpp5k and Myo1c as novel tumor suppressor gene candidates in this
region
Carola Oldfors Hedberg, Diego Garcia Dios, Anna Linder, Kittichate Visuttijai, Emma Samuelson, S. Karlsson, Staffan Nilsson, A. Behboudi
BMC Genetics - 2015-01-01